Cell Therapy Cancer Cure Business Case
This week’s medical breakthrough sees the unusual sight of a lifetime costing
sell make national news.
It concerns big pharma Novartis. Specifically their new item, car-t; list price
£282,000.
It’s a “revolutionary treatment that re-engineers the immune system to fight
cancer”.
In this particular cause, a rare